SavedAdd your journal

Journals / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Comparison of the healing effects of activated protein c and triiodothyronine replacements in the late period of experimental sepsis

Bahadir KULAH
Hakan KULAÇOĞLU
Celil UĞURLU
Bülent KOCA
Ata Türker ARIOK
Pages
259–266
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our study showed that both activated protein C and Tri-iodothyronine can be effective in the host's response to infection in the late period of sepsis, alone and in a single dose.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sepsis is one of the most serious problems in intensive care units due to its high morbidity and mortality.
📊
Key Findings & Data:Twenty-four Wistar Albino male rats were divided into 4 groups, including the control group, septic group, Activated Protein C (APC), and Tri-Iodothyronine (T3) treatment groups.
💡
Conclusion & Impact:Our study showed that both activated protein C and Tri-iodothyronine can be effective in the host's response to infection in the late period of sepsis, alone and in a single dose.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sepsis is one of the most serious problems in intensive care units due to its high morbidity and mortality. Objective of the study to compare the healing effects of Activated Protein C and Tri-Iodothyronine in the late period of experimental sepsis. Twenty-four Wistar Albino male rats were divided into 4 groups, including the control group, septic group, Activated Protein C (APC), and Tri-Iodothyronine (T3) treatment groups. Leukocyte, thrombocyte, IL-1, IL-6, TNF-α, and antithrombin-III levels were investigated. Histopathological evaluation was performed by taking the liver, lung and intestinal tissue samples. The APC and T3 replacement groups were compared with the septic rat group, and it was observed that they preserved thrombocyte levels and antithrombin III levels, suppressed interleukin levels, and limited the effects of inflammatory responses in the liver, intestine and lung tissue. Leukocyte levels were found to be significantly higher in the T3 replacement group than in the septic group, while there was no significant difference between the APC group and the septic group. Our study showed that both activated protein C and Tri-iodothyronine can be effective in the host's response to infection in the late period of sepsis, alone and in a single dose.

🔖

Cite This Article

KULAH, B., KULAÇOĞLU, H., UĞURLU, C., KOCA, B., ARIOK, A. T. (2022). Comparison of the healing effects of activated protein c and triiodothyronine replacements in the late period of experimental sepsis. Medicine Science, Cilt: 11 - Sayı: 1, 259–266. https://ajindex.com/articles/579596

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Salomão R, Ferreira BL, Salomão MC, et al. Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019;52:e8595
  2. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10
  3. Yang S, Koo DJ, Chaudry IH, Wang P. The important role of the gut in initiating the hyperdynamic response during early sepsis. Journal of Surgical Research. 2000; 89:31-7
  4. Prigent H, Maxime V, Annane D. Science review: mechanisms of impaired adrenal function in sepsis nd molecular actions of glucocorticoids. Crit Care. 2004;8:243- 52 5. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699- 709
  5. O'Brien JM Jr, Abraham E. New Approaches To The Treatment of Sepsis. Clin Chest Med. 2003;24:521-48
  6. İnan M, Koyuncu A, Aydın C, et al. Thyroid hormone supplementation in sepsis: An experimental study. Surgery Today. 2003;33:24-29
  7. Pareker SJ, Watkins PE. Experimental models of gram negative sepsis. B J Surg. 2001;88:22-30
  8. Wang P, Zhou M, Cioffi WG, et al. Is Prostacyclin Responsible For Producing The Hyperdynamic Response During Early Sepsis. Crit Care Med. 2000;28:1534-39 10. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care. 2003;7:130-8
  9. Dixon B. The Role of Microvascular Thrombosis in Sepsis. Anesthesia and Intensive Care. 2004;32:619-29
  10. Dellinger P. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis. 2003;36:1259-65
  11. Bedet A, Razazi K, Boissier F, et al. Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators. Shock. 2018;49:641-8
  12. Favory R, Poissy J, Alves I, et al. Activated protein C improves macrovascular and microvascular reactivity in human severe sepsis and septic shock. Shock. 2013;40512-18
  13. Dhainaut JF, Laterre PF, Janes JM, et al. Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med. 2003;29:894-903
  14. Vincent JL, Bernard GR, Beale R, et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005;33:2266-77
  15. Fontes KN, Cabanelas A, Bloise FF, e